[Table/Fig-1]:
Demographics of SABS Cohort.
| Overall (n=211) | Survivors (n=151) |
Non-survivors (n=60) |
|
|---|---|---|---|
| Age (mean ± SD) | 62.8 ± 15.2 | 60.7 ± 15.0 | 67.9 ± 14.5 |
| Female (%) | 47.9 | 50.3 | 41.2 |
| Underlying metastatic cancer, leukaemia, or lymphoma (n) | 28 | 17 | 11 |
| Aetiology n (% within category) | |||
| Large bowel perforation | 33 (15.6) | 24 (15.9) | 9 (14.8) |
| Small bowel perforation | 31 (14.7) | 21 (13.9) | 10 (16.4) |
| Ischemia/infarction | 31 (14.7) | 20 (13.2) | 11 (18) |
| Anastamotic failure | 30 (14.2) | 22 (14.6) | 8 (13.1) |
| C. difficile Colitis | 14 (6.6) | 8 (5.3) | 6 (9.8) |
| Abscess (intra-abdominal) | 13 (6.2) | 12 (7.9) | 1 (1.6) |
| Other (multiple sources, gynecologic, fecal impaction, iatrogenic) | 12 (5.7) | 10 (6.6) | 2 (3.3) |
| Small bowel obstruction | 9 (4.3) | 6 (4.0) | 3 (4.9) |
| Necrotizing Pancreatitis | 9 (4.3) | 7 (4.6) | 2 (3.3) |
| Gastric perforation | 7 (3.3) | 6 (4.0) | 1 (1.6) |
| Abdominal wall | 6 (2.8) | 5 (3.3) | 1 (1.6) |
| Biliary complication | 6 (2.8) | 2 (1.3) | 4 (6.6) |
| Large bowel obstruction | 4 (1.9) | 3 (2.0) | 1 (1.6) |
| Typhlitis | 2 (0.9) | 2 (1.3) | 0 |
| Fistula | 3 (1.4) | 6 (4.0) | 1 (1.6) |
| Ulcerative colitis | 1 (0.5) | 1 (0.7) | 0 |